APLS — APELLIS PHARMACEUTICALS INC

Ownership history in FOX RUN MANAGEMENT, L.L.C.  ·  8 quarters on record

This page tracks every 13F SEC filing in which FOX RUN MANAGEMENT, L.L.C. reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.29% (2022 Q3)
Avg. % of fund
0.11%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 27,223 +13,256 +94.9% 0.10% $616K $22.63
2025 Q2 REDUCED 13,967 -1,745 -11.1% 0.04% $242K $17.31
2025 Q1 REDUCED 15,712 -6,390 -28.9% 0.05% $344K $21.87
2024 Q2 ADDED 22,102 +16,867 +322.2% 0.16% $848K $38.36
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22%
← Back to FOX RUN MANAGEMENT, L.L.C. Holdings